French To Speed Up Early Access Procedure
Drug Price Cuts Also In The Offing, But Less Than Expected
The French government is to implement a simplified mechanism for making new, innovative medicines available to patients more quickly before they are formally approved for marketing. The target for reimbursement spending on health care in general has been increased for 2021 and includes a special provision for coronavirus-related expenditure.
You may also be interested in...
As negotiations between the UK and EU enter a crucial phase, the UK life sciences industry has called for more clarity and guidance on what companies can expect to face at the end of the Brexit transition period.
A legislative provision under which future COVID-19 vaccines can be made available in the UK before they are approved is also being used to offer an unlicensed flu vaccine that officials say has undergone full safety, efficacy and quality tests.
With product shortages made worse by the pandemic, companies in the UK are being asked to use a new system for notifying potential supply disruptions and any plans to discontinue specific medicines.